Latest Revenue Growth News

Nova Eye Medical has reported a record A$29.2 million revenue for FY25, driven by strong sales growth and improved profitability in its glaucoma segment. The company targets breakeven EBITDA in the first half of FY26 amid promising regulatory and market developments.

Freelancer Limited has reported its strongest half-year profit to date, driven by growth across its freelancing, escrow, and freight platforms, while setting ambitious targets for AI productisation and double-digit revenue growth in FY25.

Mach7 Technologies has updated its FY25 guidance, reporting positive cash flow and a solid financial position, while appointing Teri Thomas as its new CEO to steer the company’s next growth phase.

BSA Limited reported a 7% increase in FY25 revenue to $286.8 million and a 42% rise in EBITDA pre-significant items, despite losing key contracts that accounted for 92% of its revenue. The company is undertaking significant restructuring to navigate these challenges.

Mach7 Technologies closes FY25 with solid recurring revenue growth, positive cash flow, and a refreshed leadership team focused on innovation and customer value.

De.mem Limited has reported its second highest quarterly cash receipts ever, alongside a fourth consecutive quarter of positive operating cash flow, positioning the company for a record full-year 2025 performance.

Freelancer Limited has reported a landmark half-year profit, driven by strong revenue growth, AI project demand, and a major NASA contract win. Operational advances across its platforms underscore a promising outlook.

Freelancer Limited has posted a notable financial turnaround in the first half of 2025, reporting a net profit of $1.9 million on the back of 8.5% revenue growth and improved cash flow. The company’s strengthened balance sheet and strategic share acquisition position it well for future growth.

Advanced Braking Technology Ltd (ABT) posted a robust FY25 with sales up 27% and underlying profits nearly doubling, driven by strong international demand and innovation milestones.

Bioxyne Limited has reported record revenue and cash flow for FY25, driven by robust growth in the Australian medical cannabis market and strategic advances into Europe and the UK.

Adveritas Limited reports a robust 62% increase in annualised recurring revenue to $10.47 million and a record doubling of full-year cash receipts, backed by a strategic $8.5 million institutional placement to accelerate growth in the US and new verticals.

Beforepay Group Limited reported a record Q4 FY25 with a 76% increase in net profit before tax, driven by strong revenue growth and strategic U.S. partnerships through Carrington Labs.